Evidence map›Paper›PMID 41840009›Full record

ArticleActa pharmacologica Sinica2026

Neuronal mitochondrial dynamics: roles in brain disorders and therapeutic potential.

Xing-Xian Zhang, Jia-Min Du, Shen-Zhan Wang, Xin-Lei Mo, Xiang-Nan Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Acta pharmacologica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xing-Xian Zhang *Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang Key Laboratory of Neuropsychopharmacology, Zhejiang University, Hangzhou, 310058, China.
Jia-Min Du *Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang Key Laboratory of Neuropsychopharmacology, Zhejiang University, Hangzhou, 310058, China.
Shen-Zhan WangInstitute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang Key Laboratory of Neuropsychopharmacology, Zhejiang University, Hangzhou, 310058, China.
Xin-Lei MoInstitute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang Key Laboratory of Neuropsychopharmacology, Zhejiang University, Hangzhou, 310058, China.
Xiang-Nan ZhangInstitute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang Key Laboratory of Neuropsychopharmacology, Zhejiang University, Hangzhou, 310058, China. xiangnan_zhang@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial dynamics - processes that include fission, fusion, transport, and mitophagy - are essential for shaping mitochondrial form and function to meet neuronal homeostatic demands. Growing evidence links imbalances in these processes to the pathogenesis of multiple brain disorders. In this review we comprehensively summarize the molecular mechanisms that govern mitochondrial dynamics and clarify their roles in key neuronal functions, including synaptic transmission, vesicle recycling, and calcium buffering. We also examine how disruptions in mitochondrial dynamics drive synaptic dysfunction and neuronal injury, with specific implications for neurodegenerative and psychiatric disorders. Finally, we evaluate emerging therapeutic strategies that target mitochondrial dynamics - both pharmacological and genetic - and highlight their promise as novel therapies for brain disorders. This synthesis provides an in-depth perspective on mitochondrial dynamics in brain health and disease and aims to guide future research and drug development.

Indexed as

mitochondrial dynamicsneurodegenerationsneuronneuropsychiatric disorderstherapeutic strategy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.